BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33607176)

  • 1. Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles.
    Li G; He S; Schätzlein AG; Weiss RM; Martin DT; Uchegbu IF
    J Control Release; 2021 Apr; 332():210-224. PubMed ID: 33607176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model.
    Erdoğar N; Iskit AB; Eroğlu H; Sargon MF; Mungan NA; Bilensoy E
    J Nanosci Nanotechnol; 2015 Dec; 15(12):10156-64. PubMed ID: 26682462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Boronated Chitosan as a Mucoadhesive Polymer for Intravesical Drug Delivery.
    Kolawole OM; Lau WM; Khutoryanskiy VV
    J Pharm Sci; 2019 Sep; 108(9):3046-3053. PubMed ID: 31091425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
    Erdogar N; İskit AB; Eroglu H; Sargon MF; Mungan NA; Bilensoy E
    Int J Pharm; 2014 Aug; 471(1-2):1-9. PubMed ID: 24836669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall.
    Grabnar I; Bogataj M; Mrhar A
    Int J Pharm; 2003 Apr; 256(1-2):167-73. PubMed ID: 12695023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder wall penetration of intravesical mitomycin C in dogs.
    Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
    Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
    Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced permeability of the urinary bladder wall: the role of polymer charge.
    Kerec Kos M; Bogataj M; Mrhar A
    Pharmazie; 2009 Apr; 64(4):232-7. PubMed ID: 19435140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.
    Siemens DR; Austin JC; See WA; Tartaglia J; Ratliff TL
    J Urol; 2001 Feb; 165(2):667-71. PubMed ID: 11176455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury.
    Griffin JI; Cheng SKK; Hayashi T; Carson D; Saraswathy M; Nair DP; Simberg D
    Nanomedicine; 2017 Aug; 13(6):1925-1932. PubMed ID: 28428051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
    Li G; Lei Q; Wang F; Deng D; Wang S; Tian L; Shen W; Cheng Y; Liu Z; Wu S
    Small; 2019 Jun; 15(25):e1900936. PubMed ID: 31074941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic model of drug distribution in the urinary bladder wall following intravesical instillation.
    Grabnar I; Bogataj M; Belic A; Logar V; Karba R; Mrhar A
    Int J Pharm; 2006 Sep; 322(1-2):52-9. PubMed ID: 16806751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of mitomycin C in human bladder.
    Wientjes MG; Badalament RA; Wang RC; Hassan F; Au JL
    Cancer Res; 1993 Jul; 53(14):3314-20. PubMed ID: 8324743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.
    Mugabe C; Raven PA; Fazli L; Baker JH; Jackson JK; Liggins RT; So AI; Gleave ME; Minchinton AI; Brooks DE; Burt HM
    Biomaterials; 2012 Jan; 33(2):692-703. PubMed ID: 22014457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-coated nanodiamonds: Mucoadhesive platform for intravesical delivery of doxorubicin.
    Ali MS; Metwally AA; Fahmy RH; Osman R
    Carbohydr Polym; 2020 Oct; 245():116528. PubMed ID: 32718632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
    Kaldybekov DB; Filippov SK; Radulescu A; Khutoryanskiy VV
    Eur J Pharm Biopharm; 2019 Oct; 143():24-34. PubMed ID: 31419584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.